SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950170-23-022259
Filing Date
2023-05-15
Accepted
2023-05-15 16:36:34
Documents
69
Period of Report
2023-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q bior-20230331.htm   iXBRL 10-Q 2398318
2 EX-31.1 bior-ex31_1.htm EX-31.1 22168
3 EX-31.2 bior-ex31_2.htm EX-31.2 22630
4 EX-32.1 bior-ex32_1.htm EX-32.1 19577
  Complete submission text file 0000950170-23-022259.txt   8994450

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT bior-20230331.xsd EX-101.SCH 63496
6 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT bior-20230331_lab.xml EX-101.LAB 576000
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT bior-20230331_cal.xml EX-101.CAL 52798
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT bior-20230331_def.xml EX-101.DEF 281393
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT bior-20230331_pre.xml EX-101.PRE 427298
63 EXTRACTED XBRL INSTANCE DOCUMENT bior-20230331_htm.xml XML 1396578
Mailing Address 4330 LA JOLLA VILLAGE DRIVE SUITE 200 SAN DIEGO CA 92122
Business Address 4330 LA JOLLA VILLAGE DRIVE SUITE 200 SAN DIEGO CA 92122 855-293-2639
BIORA THERAPEUTICS, INC. (Filer) CIK: 0001580063 (see all company filings)

IRS No.: 273950390 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-39334 | Film No.: 23923347
SIC: 2834 Pharmaceutical Preparations